You are viewing the site in preview mode

Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: Quantitative proteomics reveals serum proteome alterations during metastatic disease progression in breast cancer patients

Fig. 3

Kaplan-Meier plots (KM plot) describing the prognostic value of differentially expressed proteins comparing PV1 (progressors) and NP (non-progressors) collected at diagnosis. (A) KM plot of proteins whose increased expression in the diagnostic serum was significantly associated with poor clinical outcome. (B) same as in (A), but for proteins whose decreased expression in diagnostic serum was significantly associated with poor clinical outcome

Back to article page

Clinical Proteomics

ISSN: 1559-0275